SCHEMBL7990957

SCHEMBL7990957

CCOC(=O)C(c1ccncc1)C(c1ccc(Oc2ccc([N+](=O)[O-])cc2)nc1)c1ccc(OC(F)F)c(OC(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.39
HSPB1 P04792 2/20 0.37
MAPT P10636 7/20 0.37
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 2/20 0.37
MAPK1 P28482 2/20 0.37
HTT P42858 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
NPSR1 Q6W5P4 1/20 0.35
FBP1 P09467 1/20 0.34
KDM4E B2RXH2 2/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PDE4A P27815 2/20 0.34
MMP13 P45452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7994826 0.92 PDE4B (0.33) MAPTALDH1A1TDP1FBP1GAA
SCHEMBL7991148 0.87 PDE4A (0.34) FBP1PDE4AACACBACACAPDE4B
SCHEMBL7996011 0.87 LMNA (0.41) ALDH1A1LMNAL3MBTL1KDM4EKMT2A
SCHEMBL7908336 0.80 PDE4A (0.38) L3MBTL1FBP1PDE4APDE4BPDE4C
SCHEMBL7991261 0.79 HSPB1 (0.48) RAB9AHSPB1MAPTALDH1A1SMN1; SMN2
SCHEMBL7994691 0.79 PDE4A (0.53) PDE4A
SCHEMBL7992704 0.78 F7 (0.36) PDE4APDE4BPDE4CPDE4D
SCHEMBL7991279 0.77 PDE4A (0.33) FBP1PDE4APDE4BPDE4CPDE4D
SCHEMBL7977060 0.76 HSPB1 (0.48) RAB9AHSPB1MAPTALDH1A1SMN1; SMN2
SCHEMBL7904298 0.76 PDE4A (0.43) PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180650-B1 ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTITUMOR AGENTS MERCK FROSST CANADA & CO. (CA) 2001-01-30 US disclosed